ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 671,65
1,34%
Dow Jones
38 897,92
0,16%
DAX
18 217,86
0,83%
Brent Oil
85,185
0,58%
Bitcoin
64 872,71
-0,15%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX
  6. Maia Biotechnology Inc (MAIA)

  7. Maia Biotechnology Inc (MAIA) Actualités

MAIA Maia Biotechnology Inc

3,4428
-0,0972 (-2,75%)
Dernière mise à jour : 16:51:25
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Maia Biotechnology Inc MAIA AMEX Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,0972 -2,75% 3,4428 16:51:25
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
3,50 3,3195 3,5526 3,54
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
07/6/202418:31BWMAIA Biotechnology's Telomere Targeting Functionality is..
06/6/202420:57EDGAR2Form 8-K - Current report
06/6/202416:07BWMAIA Biotechnology Announces Year-to-Date Achievements and..
04/6/202422:06EDGAR2Form 8-K - Current report
04/6/202414:41BWMAIA Biotechnology Reveals New Clinical Data Showing THIO’s..
03/6/202422:05EDGAR2Form 8-K - Current report
29/5/202422:05EDGAR2Form 8-K - Current report
17/5/202414:37BWMAIA Biotechnology to Present at the BIO International..
16/5/202414:37BWMAIA Biotechnology Abstract Accepted for Poster Presentation..
15/5/202422:07EDGAR2Form 8-K - Current report
15/5/202422:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/5/202422:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202423:21EDGAR2Form 8-K - Current report
30/4/202414:08BWMAIA Biotechnology Announces Share Purchase by Director..
29/4/202414:08BWMAIA Biotechnology Announces Share Purchase by Director Stan..
23/4/202414:51BWMAIA Biotechnology Announces $1.00 Million Private Placement
05/4/202414:01BWMAIA Biotechnology to Present at Two Investor Conferences in..
28/3/202420:00BWMAIA Biotechnology Announces Share Purchases by Directors..
26/3/202420:00BWMAIA Biotechnology Announces Share Purchase by Director..
26/3/202413:01BWMAIA Biotechnology Announces $1.33 Million Private Placement
22/3/202420:00BWMAIA Biotechnology Announces Share Purchase by Director Stan..
21/3/202420:00BWMAIA Biotechnology Welcomes Prominent Medical Oncology..
08/3/202422:15EDGAR2Form 8-K - Current report
07/3/202415:45BWMAIA Biotechnology to Participate in the 36th Annual ROTH..
06/3/202417:04BWMAIA Biotechnology and Nationwide Children’s Hospital..
06/3/202414:48BWMAIA Biotechnology Announces Strong Efficacy of THIO as..
06/3/202414:00EDGAR2Form 8-K - Current report
05/3/202414:45BWMAIA Biotechnology CEO Details Immuno-Oncology Cancer..
27/2/202423:23EDGAR2Form 8-K - Current report
23/2/202422:17EDGAR2Form 8-K - Current report
14/2/202423:18EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/2/202423:15EDGAR2Form 8-K - Current report
07/2/202414:01BWMAIA Biotechnology Announces Publication in Nature..
30/1/202415:00EDGAR2Form 8-K - Current report
26/1/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202413:15BWMAIA Biotechnology Announces Publication of International..
20/1/202403:00EDGAR2Form 144 - Report of proposed sale of securities
18/1/202412:01EDGAR2Form 8-K - Current report
17/1/202415:00BWMAIA Biotechnology Provides Positive Phase 2 Clinical..
05/1/202414:00BWMAIA Biotechnology to Present at Biotech Showcase 2024 on..
04/1/202403:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202403:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202403:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202403:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202402:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202313:00EDGAR2Form 8-K - Current report
19/12/202313:00BWMAIA Biotechnology Announces Dose Selection in THIO-101..
29/11/202322:19EDGAR2Form D - Notice of Exempt Offering of Securities

Dernières Valeurs Consultées

AMEX
MAIA
Maia Biotechnology
LSE
0JYA
Marathon Petroleum
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés